DAE HWA Pharmaceutical Co. Ltd (067080) — Long-term Investment Intensity
DAE HWA Pharmaceutical Co. Ltd (067080) has a Long-term Investment Intensity of 10.9% as of September 2019. Long-term investments of ₩19.11 Billion represent 10.9% of total assets of ₩175.79 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 067080 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
DAE HWA Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2018)
This chart shows how DAE HWA Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 10.9%, reflecting long-term investments of ₩19.11 Billion against total assets of ₩175.79 Billion KRW. For the complete balance sheet picture, see 067080 asset base.
Annual Long-term Investment Intensity for DAE HWA Pharmaceutical Co. Ltd (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for DAE HWA Pharmaceutical Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of DAE HWA Pharmaceutical Co. Ltd for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 8.5% | ₩13.71 Billion | ₩162.06 Billion | ▼ -1.2 pp |
| 2017 | 9.7% | ₩16.00 Billion | ₩165.47 Billion | ▲ +4.8 pp |
| 2016 | 4.9% | ₩7.55 Billion | ₩153.80 Billion | ▼ -0.6 pp |
| 2015 | 5.5% | ₩6.80 Billion | ₩124.61 Billion | ▲ +1.4 pp |
| 2014 | 4.1% | ₩5.09 Billion | ₩124.07 Billion | — |